TY  - GEN
AB  - "The NIH contracted with the Institute of Medicine (IOM) in 2012 to conduct a study to assess and provide recommendations on appropriateness of the CTSA Program's mission and strategic goals and whether changes were needed. The committee was also tasked with providing an independent appraisal of and advice on the implementation of the program by the National Center for Advancing Translational Sciences (NCATS), while exploring the contributions of CTSAs in accelerating the development of new therapeutics, facilitating disease-specific and child health research, and enhancing the integration of research funded by NIH institutes and centers. To conduct this study, the IOM convened a 13-member committee with expertise in community outreach and engagement, public health and health policy, bioethics, education and training, pharmaceutical research and development, program evaluation, clinical and biomedical research, and child health research, along the full continuum of clinical and translation research. The committee's overarching conclusion is that the CTSA Program is contributing significantly to the advancement of clinical and translational research and is therefore a worthwhile investment that would benefit from a variety of revisions to make it more efficient and effective"--
AU  - Leshner, Alan I.,
AU  - Terry, Sharon,
AU  - Schultz, Andrea M.,
AU  - Liverman, Catharyn T.,
CN  - R854.U5
ID  - 720952
KW  - Medicine
KW  - Medicine
KW  - Medicine
KW  - Research
LK  - https://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10863849
N2  - "The NIH contracted with the Institute of Medicine (IOM) in 2012 to conduct a study to assess and provide recommendations on appropriateness of the CTSA Program's mission and strategic goals and whether changes were needed. The committee was also tasked with providing an independent appraisal of and advice on the implementation of the program by the National Center for Advancing Translational Sciences (NCATS), while exploring the contributions of CTSAs in accelerating the development of new therapeutics, facilitating disease-specific and child health research, and enhancing the integration of research funded by NIH institutes and centers. To conduct this study, the IOM convened a 13-member committee with expertise in community outreach and engagement, public health and health policy, bioethics, education and training, pharmaceutical research and development, program evaluation, clinical and biomedical research, and child health research, along the full continuum of clinical and translation research. The committee's overarching conclusion is that the CTSA Program is contributing significantly to the advancement of clinical and translational research and is therefore a worthwhile investment that would benefit from a variety of revisions to make it more efficient and effective"--
SN  - 9780309284752
T1  - The CTSA program at NIHopportunities for advancing clinical and translational research /
TI  - The CTSA program at NIHopportunities for advancing clinical and translational research /
UR  - https://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10863849
ER  -